Navigation Links
Pfizer Oncology To Present New Clinical Data Across Ten Tumor Types and Multiple Molecular Targets
Date:10/7/2010

is currently being evaluated in the BR.26 clinical trial, a Phase 3, double-blind, placebo-controlled, randomized study in patients with stage IIIB/IV NSCLC who have progressive disease following standard chemotherapy and EGFR inhibitor therapy.(3) BR.26 is led by the NCIC Clinical Trials Group (CTG).(3)

  • Crizotinib (PF-02341066)

Updated data on crizotinib (PF-02341066), a first-in-class, oral ALK inhibitor, will also be presented, from the ongoing expansion cohort from the Phase 1 study evaluating the compound in patients with ALK-positive advanced NSCLC (Abstract #366PD, October 10).(4)

  • Sunitinib

Pfizer will also present results from SUN 1087, a Phase 3 trial evaluating sunitinib plus erlotinib compared to erlotinib alone in patients with advanced NSCLC who have received at least one previous treatment with a platinum-based regimen (Abstract #LBA6, October 11).(5)  In August, Pfizer announced that this study demonstrated a statistically significant improvement in progression-free survival but not in overall survival.  Overall survival was the primary endpoint of the study and progression free survival was the secondary endpoint of the study.

Pfizer will also present progression-free survival (PFS) data as determined by blinded independent central review (BICR) from the pivotal, placebo-controlled SUN 1111 Phase 3 trial evaluating sunitinib in patients with progressive, well-differentiated pancreatic neuroendocrine tumor (NET) (Abstract #747P, October 9).(6)

  • Figitumumab

Results from a Phase 1/2 study evaluating figitumumab (CP-751,871), a selective fully human IgG2 monoclonal antibody against the IGF-1R (insulin-like growth factor 1 receptor) pathway, in patients with refractory Ewing's sarcoma and other sarcomas will be presented in a Proffe
'/>"/>

SOURCE Pfizer Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related medicine technology :

1. Wyeths Torisel and Roche/Genentechs Avastin Will Challenge Pfizers Sutent to Become the Clinical Gold Standard for Treatment of Metastatic Renal Cell Carcinoma
2. Kosans Motilin Receptor Agonist, Licensed to Pfizer, Enters Phase 1 Clinical Trial in Gastroesophageal Reflux Disease
3. Coley Pharmaceutical Group and Pfizer Nominate Additional Anti-Cancer Compound for Clinical Development
4. Rigel Announces Initiation of Phase 1 Clinical Trial of R343 for Allergic Asthma by its Partner Pfizer
5. NicOx Announces Pfizer Initiates Phase 2 Clinical Development for PF-03187207 in Japan
6. Tacere Therapeutics Enters Collaboration and License Agreement With Pfizer To Develop and Commercialize RNAi Hepatitis C Drug
7. MannKind Addresses Pfizers Announcement Regarding Exubera
8. Quark Pharmaceuticals Announces First Patient Dosing by Pfizer in Phase II Trial of RNAi Therapy in Diabetic Macular Edema
9. Silence Therapeutics to Receive $1.9m Milestone Payment as Pfizer and Quark Commence Phase II Trial
10. Medarex Receives Milestone Payment from Pfizer for Investigational New Drug Application Filing
11. Pfizer Contributes Critical Data to URMC Drug Safety Initiative
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/29/2015)... 2015  Excite Medical was established by its President, ... Excite Medical, under the leadership of Mr. Musallam ... a solid track record of providing unparalleled service and ... base.  Photo - http://photos.prnewswire.com/prnh/20150529/219412 ... been possible, in large part, due to Mr. ...
(Date:5/29/2015)... 2015 A six-hour certification program on "How ... the Cannabis World Congress & Business Exposition (CWCBExpo) ... .  Taking place on Wednesday, June 17 th ... at the leading event on the East Coast for the ... Clover Leaf University, the first cannabis university to be approved, ...
(Date:5/29/2015)... -- Eli Lilly and Company (NYSE: LLY ) ... Conference on Tuesday, June 9, 2015. Jeffrey Simmons ... will participate in a fireside chat at 2:20 p.m., ... webcast will be available on the "Webcasts & Presentations" ... A replay of the fireside chat will be available ...
Breaking Medicine Technology:Cannabis Business Certification and Career Workshops Presented at New York Trade Show & Conference 2Cannabis Business Certification and Career Workshops Presented at New York Trade Show & Conference 3Cannabis Business Certification and Career Workshops Presented at New York Trade Show & Conference 4Lilly to Participate in Goldman Sachs Global Healthcare Conference 2
... Symmetry Medical Inc. (NYSE: SMA ), a ... industry and other medical markets, announced today that it will ... October 2, 2010 before the market opens on Thursday, November ... at 8:00 a.m. ET on Thursday, November 4, 2010. ...
... ARBOR, Mich., Oct. 14 The ... Secretary for Planning and Evaluation (ASPE) has selected ... that will enable researchers to perform comparative effectiveness ... (Logo: http://photos.prnewswire.com/prnh/20090507/NY12658LOGO ) ...
Cached Medicine Technology:Symmetry Medical to Report Third Quarter 2010 Financial Results on November 4, 2010 2Federal Government Selects Thomson Reuters to Build Tool That Streamlines Comparative Effectiveness Research 2
(Date:5/30/2015)... (PRWEB) May 30, 2015 Boston ... million in punitive and compensatory damages to a ... suffered serious complications following implantation of the company’s ... verdict rendered on May 28th in Delaware Superior ... compensatory damages after the jury found that the ...
(Date:5/30/2015)... (PRWEB) May 30, 2015 At 73 years ... of vibrant health , which she attributes to a ... principles of good nutrition with the release of her new ... by Xlibris AU). , “Cook for Health and Longevity” features ... nutritious and mostly organic food . It is designed ...
(Date:5/30/2015)... May 30, 2015 Key Housing, a ... proud to announce their June 2015 featured apartment community: ... in San Francisco, Key Housing is helping those people ... what is one of the tightest apartment markets in ... posting, and understandably anyone who requires temporary San Francisco ...
(Date:5/30/2015)... Las Vegas, Nevada (PRWEB) May 30, 2015 ... effective treatment of acne scars, large pores, deep wrinkles, ... by a licensed medical professional, such as Dr. F. ... conducted some of the clinical trials in Las Vegas. ... and SmartScan technology into a system that delivers proven ...
(Date:5/29/2015)... Ready to hit the road? Before embarking on a ... their vehicles ready. With handicapped vehicles, there are even more ... is ready to help drivers get their handicapped vans ready ... , When planning for the big trip, drivers should be ... goes smoothly and they are prepared for all contingencies: ...
Breaking Medicine News(10 mins):Health News:Boston Scientific Transvaginal Mesh Lawsuit Trial Ends With $100 Million Verdict 2Health News:Boston Scientific Transvaginal Mesh Lawsuit Trial Ends With $100 Million Verdict 3Health News:Boston Scientific Transvaginal Mesh Lawsuit Trial Ends With $100 Million Verdict 4Health News:Lynn Kendall Shows How to ‘Cook for Health and Longevity’ 2Health News:Lynn Kendall Shows How to ‘Cook for Health and Longevity’ 3Health News:San Francisco Corporate Housing Leader Key Housing Designates 388 Beale Street as Featured Community for June 2Health News:San Francisco Corporate Housing Leader Key Housing Designates 388 Beale Street as Featured Community for June 3Health News:Announcing Ground-Breaking Technology for Anti-Aging, FDA Approved, Venus Viva. 2Health News:Announcing Ground-Breaking Technology for Anti-Aging, FDA Approved, Venus Viva. 3Health News:Advanced Driving Systems Offers Tips for Summer Road Trips 2Health News:Advanced Driving Systems Offers Tips for Summer Road Trips 3
... Sutter Health has announced,the appointment of Florence L. DiBenedetto ... new role January 5, 2009, succeeding longtime,General Counsel Gary ... Formerly senior partner of the Sacramento-based law ... past two decades, DiBenedetto,served for more than 10 years ...
... Progressive Lenses and Transitions® Lenses to Produce Optimal Visual Experience ... ... Two of the most distinguished names in the optical industry are ... ,Carl Zeiss Vision, a leader for 160 years in precision optics, ...
... HOLX ), a leading developer, manufacturer and supplier ... to serving the healthcare needs of women, today announced plans ... Monday, February 2, 2009 after market close. In conjunction with ... February 2, 2009 at 5:00 p.m. (eastern). , ...
... women who donated eggs to fertility clinics reported satisfaction ... physical symptoms and 20 percent reported lasting psychological effects, ... effects of donation. , The research by scientists at ... at clinics in 20 states and is the largest ...
... Million Prescriptions , , BETHESDA, ... owned subsidiary of the Cystic Fibrosis Foundation, today announced its ... fibrosis (CF) community nationwide. , , ... one prescription and a mission to improve access to specialty ...
... Joint Commission Compliance through Patient Engagement , ... an effort to improve patient safety and standards compliance, ... (IPC) solutions, is enabling King,s Daughters Medical Center (KDMC) to ... Goal (NPSG) 16 through GetWellNetwork,s interactive PatientLife System(R) . ...
Cached Medicine News:Health News:Sutter Health Welcomes New General Counsel 2Health News:Carl Zeiss Vision and Transitions Optical Inc. Promote Pioneering Eyewear to Consumers 2Health News:Hologic, Inc. to Release First Quarter Fiscal 2009 Operating Results on Monday, February 2, 2009 2Health News:Most women report satisfaction with egg donation; some claim problems 2Health News:Most women report satisfaction with egg donation; some claim problems 3Health News:Cystic Fibrosis Services Pharmacy Celebrates 20th Anniversary 2Health News:King's Daughters Medical Center Leverages Unique Bedside Interactive Technology to Meet Requirements of Patient Safety Goal 16 2Health News:King's Daughters Medical Center Leverages Unique Bedside Interactive Technology to Meet Requirements of Patient Safety Goal 16 3
... laser beam is delivered through an ultra thin ... the operator full freedom of movement when performing ... with a wide range of handpieces. Handpieces ... mm and 16 mm. Straight and angled ...
These are the Reusable Components (minus cannula), to be used with the VersaStep™ Plus Reposable Short System....
... VERSASTEP™ Plus Short Instrument for ... ,The VERSASTEP™ Plus Short ... Length is a unique endoscopic ... in laparoscopic procedures. It is ...
... Autosuture™ Blunt Tip Trocar consists of a ... a valve body assembly. , ,The ... valve and seal to prevent gas leakage ... Autosuture™ Blunt Tip Trocar includes built-in converters ...
Medicine Products: